Director, Translational Medicine Expert (Neurodegeneration)

Job Description Summary
#LI-Hybrid Internal Title: DirectorLocation: Cambridge, MA, USAThe Director, Translational Medicine Expert (Neurodegeneration) will lead the end to end translational strategy for neurodegenerative programs, bridging preclinical research to early clinical development (Phase 1–2).This role is accountable for biomarker strategy, clinical endpoint selection, and early phase trial design, enabling efficient, data driven decision-making through key development milestones (e.g., Transition Decision Points) and ensuring competitive differentiation of neuromuscular assets.In addition, he/she oversees the planning, execution, and interpretation of clinical trials research, data collection activities and clinical operations. Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems and final reports. Support new and ongoing clinical research and clinical trials and ensure efficient and timely processing of confidentiality agreements and clinical agreements 
Job Description
Key Responsibilities:
1. Translational Strategy & Program Leadership
Define and execute integrated translational strategies across neurodegeneration programs
Lead translational components from preclinical → Phase 1/2 clinical studies
Drive program progression through key decision gates (e.g., IND, TDP, IDPA)
Ensure strong mechanistic linkage between target biology, biomarkers, and clinical endpoints

2. Biomarker & Endpoint Leadership
Collaborate with Biomarker Development colleagues toward development and validation of:Molecular biomarkers (tissue, blood, CSF where applicable)
Functional endpoints (strength, mobility, disease-specific measures)
Patient-reported outcomes (PROs)
Establishing quantitative biomarkers to support:Target engagement
Disease modification
Dose selection and PoC decisions

Integrate biomarker strategy into clinical protocols and operational plans
Drive early biomarker de‑risking, a key priority in neuromuscular programs

 
3. Early Clinical Development (Phase 1/2)
Co‑lead design and execution of early clinical studies
Define:Dose escalation strategy
Exposure–response framework
Translational endpoints (biopsy, imaging, functional)

Ensure TM leadership within Clinical Trial Teams (CTTs) for:Trial design
Execution oversight
Data interpretation and decision-making

4. Cross-Functional Leadership
Serve as core Translational Medicine representative within global project teams
Partner closely with:Clinical Development
Biomarker Development
Clinical Pharmacology (PKS)
Preclinical Safety (PCS)
Regulatory

Drive alignment between research, TM, and development organizations

5. External Scientific Leadership
Build and lead collaborations with:Academic KOLs
Patient advocacy groups (critical in rare neuromuscular disease)
Technology partners (imaging, omics platforms)

Contribute to scientific strategy and external positioning of programs

6. Patient-Centered Development
Integrate the patient voice into translational and clinical strategies
Advance:Meaningful functional endpoints
Patient-relevant outcome measures
Innovative trial approaches (e.g., decentralized models where feasible)

7. Portfolio Contribution & Strategic Input
Contribute to:Asset prioritization and portfolio strategy
Competitive differentiation strategy (e.g., vs RNA or gene therapy competitors)

Provide scientific input to:Business development / due diligence
Indication expansion strategies

Essential Requirements:
·       MD, neurologists, clinical training in neurodegenerative diseases
·       Experience in translational medicine, early clinical development, or experimental therapeutics.
·       Ability to shape development strategies, execute early clinical studies, and influence regulatory/packages supporting differentiation.
Desirable Requirements:
·       Experience working in pharmaceutical/biotech company strongly preferred.
·       PhD, PharmD, or equivalent in:
o   Neurology / Neuroscience
o   Neurodegenerative diseases
 
The salary for this position is expected to range between: $248,500--$461,500/year
The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors. Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.
US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.
To learn more about the culture, rewards and benefits we offer our people click here.
 
EEO Statement:

The Novartis Group of Companies are Equal Opportunity Employers. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. 
 
Accessibility and reasonable accommodations

The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or to perform the essential functions of a position, please send an e-mail to us.reasonableaccommodations@novartis.com or call +1(877)395-2339 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
 
Salary Range
$248,500.00 - $461,500.00 
Skills Desired
Clinical Trials, Data Analysis, Data Monitoring, Drug Development, Medical Research, People Management